D CEO and Dallas Innovates are proud to announce the finalists for its third annual Innovation Awards and Spark Biomedical is on the list of contenders for Startup Innovator of the Year.
FinPay LLC, a recognized leader in pre-care payments and patient engagement, announced an agreement with Spark Biomedical, Inc., a Texas-based medical device company and developer of the first FDA-cleared, drug-free, personalized, wearable neurostimulation solution for opioid withdrawal — the Sparrow Therapy System.
First residential treatment center in the nation to offer The Sparrow™ Therapy System.
